Concepedia

Enhancement of intermittent androgen ablation by “off‐cycle” maintenance with finasteride in LNCaP prostate cancer xenograft model

Scott E. Eggener, Jeff A. Stern, Pankaj Jain, Shane Oram, Junkui Ai, Xiaoyan Cai, Kim Roehl, Zhou Wang

The Prostate · 2005 · 34 citations · 28 references

DOI

Abstract

IAA with finasteride provides the most favorable tumor growth kinetics and survival compared to both CAA and standard IAA.

References

28

The Influence of Finasteride on the Development of Prostate Cancer

Ian M. Thompson, Phyllis J. Goodman, Catherine M. Tangen et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer

Mary‐Ellen Taplin, Glenn J. Bubley, Todd D. Shuster et al. · New England Journal of Medicine · 1995 · 1.3K citations · Full text

A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens

Jos Veldscholte, C. Ris-Stalpers, George G. J. M. Kuiper et al. · Biochemical and Biophysical Research Communications · 1990 · 939 citations · Full text

, , +9

Tumor measurement in the nude mouse

David Euhus, Charles Hudd, Marie C. LaRegina et al. · Journal of Surgical Oncology · 1986 · 607 citations

National Practice Patterns and Time Trends in Androgen Ablation for Localized Prostate Cancer

Matthew R. Cooperberg, Gary D. Grossfeld, Deborah P. Lubeck et al. · JNCI Journal of the National Cancer Institute · 2003 · 334 citations · Full text